Report Detail
Global (United States, European Union and China) Alcohol Addiction Therapeutics Market Research Report 2019-2025
- RnM3364374 |
- 14 July, 2020 |
- Global |
- 153 Pages |
- QYResearch |
- Pharma & Healthcare
Alcohol Addiction Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcohol Addiction Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alcohol Addiction Therapeutics market is segmented into
CM-1212
CTDP-002
A-705253
ABT-436
ADX-71441
Others
Segment by Application, the Alcohol Addiction Therapeutics market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Alcohol Addiction Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alcohol Addiction Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alcohol Addiction Therapeutics Market Share Analysis
Alcohol Addiction Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alcohol Addiction Therapeutics business, the date to enter into the Alcohol Addiction Therapeutics market, Alcohol Addiction Therapeutics product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc
1 Study Coverage
- 1.1 Alcohol Addiction Therapeutics Product Introduction
- 1.2 Market Segments
- 1.3 Key Alcohol Addiction Therapeutics Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type
- 1.4.2 CM-1212
- 1.4.3 CTDP-002
- 1.4.4 A-705253
- 1.4.5 ABT-436
- 1.4.6 ADX-71441
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Alcohol Addiction Therapeutics Market Size, Estimates and Forecasts
- 2.1.1 Global Alcohol Addiction Therapeutics Revenue 2015-2026
- 2.1.2 Global Alcohol Addiction Therapeutics Sales 2015-2026
- 2.2 Global Alcohol Addiction Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alcohol Addiction Therapeutics Competitor Landscape by Players
- 3.1 Alcohol Addiction Therapeutics Sales by Manufacturers
- 3.1.1 Alcohol Addiction Therapeutics Sales by Manufacturers (2015-2020)
- 3.1.2 Alcohol Addiction Therapeutics Sales Market Share by Manufacturers (2015-2020)
- 3.2 Alcohol Addiction Therapeutics Revenue by Manufacturers
- 3.2.1 Alcohol Addiction Therapeutics Revenue by Manufacturers (2015-2020)
- 3.2.2 Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Alcohol Addiction Therapeutics Revenue in 2019
- 3.2.5 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Alcohol Addiction Therapeutics Price by Manufacturers
- 3.4 Alcohol Addiction Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Alcohol Addiction Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Alcohol Addiction Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Alcohol Addiction Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Alcohol Addiction Therapeutics Market Size by Type (2015-2020)
- 4.1.1 Global Alcohol Addiction Therapeutics Sales by Type (2015-2020)
- 4.1.2 Global Alcohol Addiction Therapeutics Revenue by Type (2015-2020)
- 4.1.3 Alcohol Addiction Therapeutics Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Alcohol Addiction Therapeutics Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Alcohol Addiction Therapeutics Sales Forecast by Type (2021-2026)
- 4.2.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Type (2021-2026)
- 4.2.3 Alcohol Addiction Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Alcohol Addiction Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Alcohol Addiction Therapeutics Market Size by Application (2015-2020)
- 5.1.1 Global Alcohol Addiction Therapeutics Sales by Application (2015-2020)
- 5.1.2 Global Alcohol Addiction Therapeutics Revenue by Application (2015-2020)
- 5.1.3 Alcohol Addiction Therapeutics Price by Application (2015-2020)
- 5.2 Alcohol Addiction Therapeutics Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Alcohol Addiction Therapeutics Sales Forecast by Application (2021-2026)
- 5.2.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Alcohol Addiction Therapeutics Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Alcohol Addiction Therapeutics by Country
- 6.1.1 North America Alcohol Addiction Therapeutics Sales by Country
- 6.1.2 North America Alcohol Addiction Therapeutics Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Alcohol Addiction Therapeutics Market Facts & Figures by Type
- 6.3 North America Alcohol Addiction Therapeutics Market Facts & Figures by Application
7 Europe
- 7.1 Europe Alcohol Addiction Therapeutics by Country
- 7.1.1 Europe Alcohol Addiction Therapeutics Sales by Country
- 7.1.2 Europe Alcohol Addiction Therapeutics Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Alcohol Addiction Therapeutics Market Facts & Figures by Type
- 7.3 Europe Alcohol Addiction Therapeutics Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Alcohol Addiction Therapeutics by Region
- 8.1.1 Asia Pacific Alcohol Addiction Therapeutics Sales by Region
- 8.1.2 Asia Pacific Alcohol Addiction Therapeutics Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Alcohol Addiction Therapeutics Market Facts & Figures by Type
- 8.3 Asia Pacific Alcohol Addiction Therapeutics Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Alcohol Addiction Therapeutics by Country
- 9.1.1 Latin America Alcohol Addiction Therapeutics Sales by Country
- 9.1.2 Latin America Alcohol Addiction Therapeutics Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Alcohol Addiction Therapeutics Market Facts & Figures by Type
- 9.3 Central & South America Alcohol Addiction Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Alcohol Addiction Therapeutics by Country
- 10.1.1 Middle East and Africa Alcohol Addiction Therapeutics Sales by Country
- 10.1.2 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Alcohol Addiction Therapeutics Market Facts & Figures by Type
- 10.3 Middle East and Africa Alcohol Addiction Therapeutics Market Facts & Figures by Application
11 Company Profiles
- 11.1 AstraZeneca Plc
- 11.1.1 AstraZeneca Plc Corporation Information
- 11.1.2 AstraZeneca Plc Description and Business Overview
- 11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Products Offered
- 11.1.5 AstraZeneca Plc Related Developments
- 11.2 BioCorRx Inc
- 11.2.1 BioCorRx Inc Corporation Information
- 11.2.2 BioCorRx Inc Description and Business Overview
- 11.2.3 BioCorRx Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Products Offered
- 11.2.5 BioCorRx Inc Related Developments
- 11.3 Bionex Pharmaceuticals LLC
- 11.3.1 Bionex Pharmaceuticals LLC Corporation Information
- 11.3.2 Bionex Pharmaceuticals LLC Description and Business Overview
- 11.3.3 Bionex Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Products Offered
- 11.3.5 Bionex Pharmaceuticals LLC Related Developments
- 11.4 Cerecor Inc
- 11.4.1 Cerecor Inc Corporation Information
- 11.4.2 Cerecor Inc Description and Business Overview
- 11.4.3 Cerecor Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Cerecor Inc Alcohol Addiction Therapeutics Products Offered
- 11.4.5 Cerecor Inc Related Developments
- 11.5 Chronos Therapeutics Ltd
- 11.5.1 Chronos Therapeutics Ltd Corporation Information
- 11.5.2 Chronos Therapeutics Ltd Description and Business Overview
- 11.5.3 Chronos Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Products Offered
- 11.5.5 Chronos Therapeutics Ltd Related Developments
- 11.6 Corcept Therapeutics Inc
- 11.6.1 Corcept Therapeutics Inc Corporation Information
- 11.6.2 Corcept Therapeutics Inc Description and Business Overview
- 11.6.3 Corcept Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Products Offered
- 11.6.5 Corcept Therapeutics Inc Related Developments
- 11.7 Curemark LLC
- 11.7.1 Curemark LLC Corporation Information
- 11.7.2 Curemark LLC Description and Business Overview
- 11.7.3 Curemark LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Curemark LLC Alcohol Addiction Therapeutics Products Offered
- 11.7.5 Curemark LLC Related Developments
- 11.8 Eli Lilly and Company
- 11.8.1 Eli Lilly and Company Corporation Information
- 11.8.2 Eli Lilly and Company Description and Business Overview
- 11.8.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Products Offered
- 11.8.5 Eli Lilly and Company Related Developments
- 11.9 Ethypharm SA
- 11.9.1 Ethypharm SA Corporation Information
- 11.9.2 Ethypharm SA Description and Business Overview
- 11.9.3 Ethypharm SA Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Ethypharm SA Alcohol Addiction Therapeutics Products Offered
- 11.9.5 Ethypharm SA Related Developments
- 11.10 H. Lundbeck A/S
- 11.10.1 H. Lundbeck A/S Corporation Information
- 11.10.2 H. Lundbeck A/S Description and Business Overview
- 11.10.3 H. Lundbeck A/S Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Products Offered
- 11.10.5 H. Lundbeck A/S Related Developments
- 11.1 AstraZeneca Plc
- 11.1.1 AstraZeneca Plc Corporation Information
- 11.1.2 AstraZeneca Plc Description and Business Overview
- 11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Products Offered
- 11.1.5 AstraZeneca Plc Related Developments
- 11.12 Indivior Plc
- 11.12.1 Indivior Plc Corporation Information
- 11.12.2 Indivior Plc Description and Business Overview
- 11.12.3 Indivior Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Indivior Plc Products Offered
- 11.12.5 Indivior Plc Related Developments
- 11.13 Kinnov Therapeutics SAS
- 11.13.1 Kinnov Therapeutics SAS Corporation Information
- 11.13.2 Kinnov Therapeutics SAS Description and Business Overview
- 11.13.3 Kinnov Therapeutics SAS Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Kinnov Therapeutics SAS Products Offered
- 11.13.5 Kinnov Therapeutics SAS Related Developments
- 11.14 Kyorin Pharmaceutical Co Ltd
- 11.14.1 Kyorin Pharmaceutical Co Ltd Corporation Information
- 11.14.2 Kyorin Pharmaceutical Co Ltd Description and Business Overview
- 11.14.3 Kyorin Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Kyorin Pharmaceutical Co Ltd Products Offered
- 11.14.5 Kyorin Pharmaceutical Co Ltd Related Developments
- 11.15 Lohocla Research Corp
- 11.15.1 Lohocla Research Corp Corporation Information
- 11.15.2 Lohocla Research Corp Description and Business Overview
- 11.15.3 Lohocla Research Corp Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Lohocla Research Corp Products Offered
- 11.15.5 Lohocla Research Corp Related Developments
- 11.16 Montisera Ltd
- 11.16.1 Montisera Ltd Corporation Information
- 11.16.2 Montisera Ltd Description and Business Overview
- 11.16.3 Montisera Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Montisera Ltd Products Offered
- 11.16.5 Montisera Ltd Related Developments
- 11.17 Omeros Corp
- 11.17.1 Omeros Corp Corporation Information
- 11.17.2 Omeros Corp Description and Business Overview
- 11.17.3 Omeros Corp Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Omeros Corp Products Offered
- 11.17.5 Omeros Corp Related Developments
- 11.18 Opiant Pharmaceuticals Inc
- 11.18.1 Opiant Pharmaceuticals Inc Corporation Information
- 11.18.2 Opiant Pharmaceuticals Inc Description and Business Overview
- 11.18.3 Opiant Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Opiant Pharmaceuticals Inc Products Offered
- 11.18.5 Opiant Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Alcohol Addiction Therapeutics Market Estimates and Projections by Region
- 12.1.1 Global Alcohol Addiction Therapeutics Sales Forecast by Regions 2021-2026
- 12.1.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Regions 2021-2026
- 12.2 North America Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
- 12.2.1 North America: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
- 12.2.2 North America: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
- 12.2.3 North America: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
- 12.3 Europe Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
- 12.3.1 Europe: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
- 12.3.2 Europe: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
- 12.3.3 Europe: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Alcohol Addiction Therapeutics Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
- 12.5.2 Latin America: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Alcohol Addiction Therapeutics Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Alcohol Addiction Therapeutics Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Alcohol Addiction Therapeutics Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Alcohol Addiction Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Alcohol Addiction Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Alcohol Addiction Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Alcohol Addiction Therapeutics. Industry analysis & Market Report on Alcohol Addiction Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Alcohol Addiction Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Alcohol Addiction Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
